Compass Therapeutics, Inc.CMPXNASDAQ
LOADING
|||
EV to Sales: Premium Valuation
Above historical average.
Left:
||||
Enterprise value to sales ratio
Latest
190.54
↑ 600% above average
Average (6y)
27.22
Historical baseline
Range
High:190.54
Low:0.00
Volatility
700.0%
High variability
| Period | Value | Change |
|---|---|---|
| 2024 | 190.54 | - |
| 2023 | 0.00 | - |
| 2022 | 0.00 | - |
| 2021 | 0.00 | - |
| 2020 | 0.00 | - |
| 2019 | 0.00 | - |
| 2018 | 0.00 | - |